Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.56 |
| ▸ | HPSE | Q9Y251 | 7/20 | 0.53 |
| ▸ | FGF2 | P09038 | 1/20 | 0.52 |
| ▸ | GBA1 | P04062 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | IGF2R | P11717 | 4/20 | 0.43 |
| ▸ | TERT | O14746 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18710686 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL20531001 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL1392875 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL13857738 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL21628176 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL21628175 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL13857778 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL13857773 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL21628177 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL13858216 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6315981-B1 | USED FOR OBTAINING IMAGE OF AN INTERNAL REGION OF HUMANS | IMARX THERAPEUTICS, INC. | 2001-11-13 | — | — | US | claimed |
| EP-0760684-A4 | GAS FILLED MICROSPHERES AS COMPUTED TOMOGRAPHY CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP (US) | 2000-03-15 | — | — | EP | claimed |
| EP-0740528-A4 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX PHARMACEUTICAL CORP (US) | 1998-04-01 | — | — | EP | claimed |
| US-5733572-A | Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles | IMARX PHARMACEUTICAL CORP. (US) | 1998-03-31 | — | — | US | claimed |
| JP-H10500692-A | — | — | 1998-01-20 | — | — | JP | claimed |
| EP-0797433-A4 | GAS FILLED MICROSPHERES AS MAGNETIC RESONANCE IMAGING CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP (US) | 1997-12-03 | — | — | EP | claimed |
| EP-0797433-A1 | GAS FILLED MICROSPHERES AS MAGNETIC RESONANCE IMAGING CONTRAST AGENTS | ImaRx Pharmaceutical Corp. (US) | 1997-10-01 | — | — | EP | claimed |
| EP-0760684-A1 | GAS FILLED MICROSPHERES AS COMPUTED TOMOGRAPHY CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1997-03-12 | — | — | EP | claimed |
| EP-0740528-A1 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX PHARMACEUTICAL CORP. (US) | 1996-11-06 | — | — | EP | claimed |
| WO-1995032006-A1 | GAS FILLED MICROSPHERES AS COMPUTED TOMOGRAPHY CONTRAST AGENTS | IMARX, PHARMACEUTICAL CORP. (US) | 1995-11-30 | — | — | WO | claimed |
| WO-1995024184-A1 | GAS FILLED MICROSPHERES AS MAGNETIC RESONANCE IMAGING CONTRAST AGENTS | UNGER EVAN C (US) | 1995-09-14 | — | — | WO | claimed |
| WO-1995015118-A1 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX PHARMACEUTICAL CORP. (US) | 1995-06-08 | — | — | WO | claimed |
| CN-111836650-B | Preparation of size-controllable microbubbles | 博莱科瑞士股份有限公司 | 2024-06-18 | — | — | CN | disclosed |
| WO-2024108091-A1 | PLATELET-BINDING PROTEINS AND CONJUGATES THEREOF, PARTICLES COMPRISING THEM AND USES THEREOF | HAIMA THERAPEUTICS, LLC (US) | 2024-05-23 | — | — | WO | disclosed |
| WO-2024108094-A1 | LYOPHILIZATION BUFFERS FOR PEPTIDE-DECORATED LIPOSOMES | HAIMA THERAPEUTICS, LLC (US) | 2024-05-23 | — | — | WO | disclosed |
| US-20240108748-A1 | COMPOSITIONS AND METHODS FOR TARGETED AMPLIFICATION OF COAGULATION AND PHAGOCYTOSIS | CASE WESTERN RESERVE UNIVERSITY | 2024-04-04 | — | — | US | disclosed |
| WO-1995032005-A1 | STABILIZED HOMOGENOUS SUSPENSIONS AS COMPUTED TOMOGRAPHY CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1995-11-30 | — | — | WO | disclosed |
| WO-1995024184-A1 | GAS FILLED MICROSPHERES AS MAGNETIC RESONANCE IMAGING CONTRAST AGENTS | UNGER EVAN C (US) | 1995-09-14 | — | — | WO | disclosed |
| WO-1995015118-A1 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX PHARMACEUTICAL CORP. (US) | 1995-06-08 | — | — | WO | disclosed |
| US-4684479-A | Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures | CAVITATION-CONTROL TECHNOLOGY, INC. | 1987-08-04 | — | — | US | disclosed |